Should we treat heart failure with phosphatase inhibitors? Better to start at the end.
Department of Physiology and Cell Biology, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA. Electronic address: Brandon.Biesiadecki@osumc.edu.
Brandon J
BJ
Biesiadecki
Department of Physiology and Cell Biology, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
Mark T
MT
Ziolo
D004791:Enzyme Inhibitors; D006333:Heart Failure; D006801:Humans; D009206:Myocardium; D010749:Phosphoprotein Phosphatases; D010744:Phosphoric Monoester Hydrolases; D054645:Protein Phosphatase 1
D004791:Enzyme Inhibitors; D010749:Phosphoprotein Phosphatases; D054645:Protein Phosphatase 1; D010744:Phosphoric Monoester Hydrolases
Myofilament phosphorlyation; PP1; Troponin I